SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-032992
Filing Date
2023-07-14
Accepted
2023-07-14 16:06:03
Documents
13
Period of Report
2023-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20230712.htm   iXBRL 8-K 61445
2 EX-10.1 lyra-ex10_1.htm EX-10.1 57770
  Complete submission text file 0000950170-23-032992.txt   244301

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20230712_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20230712_pre.xml EX-101.PRE 9848
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20230712.xsd EX-101.SCH 2481
7 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20230712_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 231089180
SIC: 3841 Surgical & Medical Instruments & Apparatus